Synthesis and microbiological activity of some novel 5- or 6-methyl-2- (2,4-disubstituted phenyl) benzoxazole derivatives

Farmaco

Volumn 53, Issue 5, 1998, Pages 337-341

  Temiz, Özlem ^a   Ören, Ilkay ^a   Şener, Esin ^a   Yalçin, Ismail ^a   Uçartürk, Nejat ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antibacterial activity; Antifungal activity; Benzoxazoles

Indexed keywords

5 METHYL 2 (2 FLUOROPHENYL)BENZOXAZOLE; 6 METHYL 2 (2 CHLOROPHENYL)BENZOXAZOLE; AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; BENZOXAZOLE DERIVATIVE; HALOPROGIN; OXICONAZOLE; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BENZOXAZOLES; CANDIDA ALBICANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032580719     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00030-5     Document Type: Article

References (18)

1. [1] L. Perrin, A. Rakik, S. Yearly, C. Baumberger, S. Kinloch-de Loies, M. Pechiere, B. Hirschel, Combined therapy with zidovudine and L-697,661 in primary HIV infection, AIDS 10 (1996) 1233-1237.
2. [2] S. Staszewski, et al., Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor, J. Infect Dis. 171 (1995) 1159-1165.
3. [3] D.B. Olsen, S.S. Carroll, J.C. Culberson, J.A. Shafer, L.C. Kuo, Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor. Nucleic Acids Res. 22 (1994) 1437-1443.
4. [4] J.S. Kim, Q. Sun, B. Gatto, C. Yu, A. Liu, L.F. Liu, E.J. La Voie, Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons, Bioorg. Med. Chem. 4 (1996) 621-630.
5. [5] C. Hubschwerlen, P. Pflieger, J.L. Specklin, K. Gubernator, H. Gmunder, P. Angehrn, I. Kompis, Pyrimido [1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors, J. Med. Chem. 35 (1992) 1385.
6. [6] D.F. Shi, T.D. Bradshaw, S. Wrigley, C.J. McCall, P. Lelieveld, I. Fichtner, M.F.G. Stevens, Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo, J. Med. Chem. 39 (1996) 3375-3384.
7. [7] I. Ören, Ö. Temiz, I. Yalçin, E. Şener, A. Akin, N. Uçartürk, Synthesis and microbiological activity of 5(or 6)-methyl-2-substituted benzoxazole and benzimidazole derivatives, Arzneim. Forsch. 47 (1997) 1393-1397.
8. [8] I. Yalçin, E. Şener, T. Özden, S. Özden, A. Akin, Synthesis and microbiological activity of 5-methyl-2-(p-substituted phenyl)-benzoxazoles, Eur. J. Med. Chem. 25 (1990) 705-708.
9. [9] E. Şener, I. Yalçin, E. Sungur, QSAR of some antifungal benzoxazoles and oxazolo(4,5-b)pyridines against C. albicans, Quant. Struc. Act. Relat. 10 (1991) 223-228.
10. [10] I. Yalçin, I. Ören, E. Şener, A. Akin, N. Uçartürk, The synthesis and the structure-activity relationships of some substituted benzoxazoles, oxazolo(4,5-b)pyridines, benzothiazoles and benzimidazoles as anti-microbial agents, Eur. J. Med. Chem. 27 (1992) 401-406.
11. [11] I. Yalçin, E. Şener, QSARs of some novel antibacterial benzimidazoles, benzoxazoles and oxazolo(4,5-b)pyridines against an enteric Gram-negative rod: K. pneumoniae, Int. J. Pharm. 98 (1993) 1-8.
12. [12] E. Şener, H. Turgut, I. Yalçin, I. Ören, L. Türker, N. Çelebi, A. Akin, Structure-activity relationships of some antimicrobial 5-substituted-2-(3-pyridyl)benzoxazoles using quantum-chemical calculations, Int. J. Pharm. 110 (1994) 109-115.
13. [13] E. Şener, I. Yalçin, Ö. Temiz, I. Ören, A. Akin, N. Uçartürk, Synthesis and structure-activity relationships of some 2,5-disubstituted benzoxazoles and benzimidazoles as antimicrobial agents, Farmaco 52 (1996) 99-103.
14. [14] F.F. Stephens, Heterocyclic compounds from Schiffs bases, Nature 164 (1949) 243.
15. [15] F.F. Stephens, J.D. Bower, The preparation of benziminazoles and benzoxazoles from Schiffs bases. Part I, J. Chem. Soc. (1949) 2971-2972.
16. [16] F.F. Stephens, J.D. Bower, The preparation of benziminazoles and benzoxazoles from Schiffs bases. Part II, J. Chem. Soc. (1950) 1722-1726.
17. [17] E.S. Charles, V.K. Agrawal, S. Sharma, R.N. Iyer, Synthesis of 2,5-disubstituted benzimidazoles as potential antihookworm and antimicrobial agents, Eur. J. Med. Chem. Chim. Ther. 14 (1979) 435-438.
18. [18] S. Shadomy,A. Espinel, in: E.H. Lennette, E.H. Spaulding, J.P. Truant (Eds.), Manual of Clinical Microbiology, 3rd ed., American Society for Microbiology, Washington, DC, 1980, p. 647.